Thomasville National Bank’s scPharmaceuticals SCPH Stock Holding History

Thomasville National Bank’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-37,500	Closed	-$213K	–	252
2025 Q3	$213K	Hold	37,500	–	–	0.01%	240
2025 Q2	$143K	Hold	37,500	–	–	0.01%	220
2025 Q1	$98.6K	Hold	37,500	–	–	0.01%	231
2024 Q4	$133K	Hold	37,500	–	–	0.01%	231
2024 Q3	$171K	Hold	37,500	–	–	0.01%	232
2024 Q2	$163K	Buy	37,500 +700	+2%	+$3.08K	0.01%	231
2024 Q1	$185K	Buy	36,800 +3,800	+12%	+$21.3K	0.02%	232
2023 Q4	$207K	Hold	33,000	–	–	0.02%	225
2023 Q3	$235K	Hold	33,000	–	–	0.02%	205
2023 Q2	$336K	Hold	33,000	–	–	0.03%	180
2023 Q1	$299K	Hold	33,000	–	–	0.03%	187
2022 Q4	$237K	Buy	33,000 +5,500	+20%	+$33.6K	0.03%	192
2022 Q3	$179K	Buy	27,500 +12,500	+83%	+$66.8K	0.02%	196
2022 Q2	$72K	Hold	15,000	–	–	0.01%	207
2022 Q1	$85K	Hold	15,000	–	–	0.01%	217
2021 Q4	$75K	Buy	+15,000	New	+$82.5K	0.01%	219

Thomasville National Bank's SCPH Position: Q4 2025 in Review

Thomasville National Bank sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 37,500 shares — an estimated $213K sold.

Thomasville National Bank first reported a position in SCPH in Q4 2021 and held it in 16 quarters. The position peaked at $336K in Q2 2023. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Thomasville National Bank reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Thomasville National Bank sold 37,500 scPharmaceuticals shares in Q4 2025, an estimated $213K.
Thomasville National Bank first reported a position in scPharmaceuticals in Q4 2021 and held it in 16 quarters.
Thomasville National Bank's scPharmaceuticals position peaked at $336K in Q2 2023.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Thomasville National Bank's 13F filing for Q4 2025, filed 26 Jan 2026.